Popular terms

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Noma patents



      

This page is updated frequently with new Noma-related patent applications.




Date/App# patent app List of recent Noma-related patents
02/04/16
20160036844 
 Explaining network anomalies using decision trees patent thumbnailExplaining network anomalies using decision trees
In an embodiment, the method comprises receiving an identification of an anomaly associated with a false positive identification of a security threat by the intrusion detection system, wherein a first set of feature data identifies features of the anomaly; creating a plurality of training sets each comprising identifications of a plurality of samples of network communications; for the anomaly and each training set of the plurality of training sets, training a decision tree that is stored in digital memory of the security analysis computer; based at least in part on the plurality of trained decision trees, extracting a set of features that distinguish the anomaly from the plurality of samples; generating one or more rules associated with the anomaly from the extracted set of features and causing programming the security analysis computer with the one or more rules.. .
Cisco Technology, Inc.


02/04/16
20160036838 
 Data center architecture that supports attack detection and mitigation patent thumbnailData center architecture that supports attack detection and mitigation
Described herein are various technologies pertaining to identification of inbound and outbound network and application attacks with respect to a data center. Commodity servers are used to monitor ingress and egress traffic flows, and anomalies are detected in the traffic flows.
Microsoft Corporation


02/04/16
20160033512 
 Diagnosis of carcinomas patent thumbnailDiagnosis of carcinomas
The invention is directed to compositions and methods for the detection of a malignant condition, and relates to the discovery of soluble and cell surface forms of he4a polypeptides, including he4a that is overexpressed in ovarian carcinomas. In particular the invention provides a nucleic acid sequence encoding he4a, and also provides a method of screening for the presence of a malignant condition in a subject by detecting reactivity of an antibody specific for a he4a polypeptide with a molecule naturally occurring in soluble and/or cell surface form in a sample from such a subject, and by hybridization screening using an he4a nucleotide sequence, as well as other related advantages..
Pacific Northwest Research Institute


02/04/16
20160033510 
 Antibodies for the identification of pancreatic disorders patent thumbnailAntibodies for the identification of pancreatic disorders
Levels of vegf-a, vegf-c and pge2 were measured in patient groups presenting with different types of pancreatic lesions. Pancreatic fluids that exhibited high levels of vegf-a and relative low levels of vegf-c correlated well with a diagnosis of serous cystadenoma.
Indiana University Research And Technology Corp.


02/04/16
20160032399 
 Method for the prognosis and treatment of renal cell carcinoma metastasis patent thumbnailMethod for the prognosis and treatment of renal cell carcinoma metastasis
The present invention relates to a method for the prognosis of bone metastasis in renal cell carcinoma which comprises determining if the c-maf gene is amplified in a primary tumor sample. Likewise, the invention also relates to a method for determining the tendency to develop bone metastasis with respect to metastasis in other organs, which comprise determining the c-maf gene expression level, amplification or translocation.
Inbiomotion S.l.


02/04/16
20160032062 
 Polymer nanocomposites patent thumbnailPolymer nanocomposites
Provided herein is technology relating to polymer nanocomposites, and particularly, but not exclusively, to polymer nanocomposites comprising two or more nanomaterials and methods of producing nanocomposites comprising two or more nanomaterials.. .
Xolve, Inc.


02/04/16
20160031810 
 Benzidine derivative,  preparing same, and pharmaceutical composition containing benzidine derivative for treating liver disease caused by hepatitis c virus patent thumbnailBenzidine derivative, preparing same, and pharmaceutical composition containing benzidine derivative for treating liver disease caused by hepatitis c virus
The disclosed compounds have antiviral activity against c-type virus, an optical isomer thereof, a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition containing the same as an active ingredient for preventing or treating liver disease caused by hepatitis c virus. The benzidine derivative according to the present invention has excellent antiviral activity against hepatitis c virus and exhibits excellent medicinal activity in the living body, and thus the pharmaceutical composition containing the same as an active ingredient can be useful as a pharmaceutical composition for preventing or treating liver disease, such as acute hepatitis c, chronic hepatitis c, cirrhosis, or hepatocellular carcinoma, caused by c-type virus..
Seoul National University R&db Foundation


02/04/16
20160030532 
 Erythrocytes containing arginine deiminase patent thumbnailErythrocytes containing arginine deiminase
Use of erythrocytes containing arginine deirainase for the preparation of a medicinal product for lowering the plasma concentration of arginine in vivo. The use relates in particular to the treatment of arginine-dependent tumors, such as hepatocarcinoma and malignant melanoma, or inhibition of the synthesis of nitric oxide, and the prevention and/or treatment of septic shock..
Erytech Pharma


01/28/16
20160028770 
 Wireless network service interfaces patent thumbnailWireless network service interfaces
A uniform wireless network service selection information exchange interface system is provided to facilitate a consistent user experience across multiple wireless networks that may have different service plan activation or service plan purchase processes. Network detection of service usage anomalies based on device-based data usage reports is provided to enable the network to determine whether an end-user device is likely operating in accordance with the established policy, or whether the end-user device may be operating fraudulently..
Headwater Partners I Llc


01/28/16
20160028762 
 Distributed supervised architecture for traffic segregation under attack patent thumbnailDistributed supervised architecture for traffic segregation under attack
In one embodiment, data flows are received in a network, and information relating to the received data flows is provided to a machine learning attack detector. Then, in response to receiving an attack detection indication from the machine teaming attack detector, a traffic segregation procedure is performed including: computing an anomaly score for each of the received data flows based on a degree of divergence from an expected traffic model, determining a subset of the received data flows that have an anomaly score that is lower than or equal to an anomaly threshold value, and providing information relating to the subset of the received data flows to the machine learning attack detector..
Cisco Technology, Inc.


01/28/16
20160028758 

System and predicting impending cyber security events using multi channel behavioral analysis in a distributed computing environment


Multi channel distributed behavioral analysis architecture provides a software solution to the major operational challenges faced with providing an early warning system for impending cyber security events. Most cyber security events are premeditated.
Zitovault, Inc.


01/28/16
20160028645 

Diagnosis of network anomalies using customer probes


Methods, apparatuses and systems for diagnosing network anomalies and allocating repair resources in a computer network receive network anomaly reports (nars) from a group of customers. Each nar specifies a network anomaly observed by a customer at a network endpoint.

01/28/16
20160025832 

System and magnetic resonance image acquisition


A method of data acquisition at a magnetic resonance imaging (mri) system is provided. The system receives at least a portion of raw data for an image, and detects anomalies in the portion of raw data received.

01/28/16
20160025789 

Harness anomaly detection systems and methods


A vehicle may include a traction battery, a harness electrically connected with the battery, and a controller programmed to generate harness anomaly output based on data indicative of historical resistances associated with the harness and temperature and state of charge data for the battery indicative of a current resistance associated with the harness.. .
Ford Global Technologies, Llc


01/28/16
20160024595 

Characterization of melanoma using a molecular signature


The present disclosure provides methods for characterizing melanoma in a subject by analyzing genes or gene expression products obtained from the subject. The present disclosure provides methods for distinguishing melanoma in situ from invasive melanoma.
Dermtech International


01/28/16
20160024587 

Markers associated with wnt inhibitors


The invention provides methods of monitoring differential gene expression of biomarkers to determine patient sensitivity to wnt inhibitor, methods of determining the sensitivity of a cell to an wnt inhibitor by measuring biomarkers, methods of screening for candidate wnt inhibitor, wnt inhibitor for use in head and neck squamous cell carcinoma.. .

01/28/16
20160024216 

Use of egfr biomarkers for the treatment of gastric cancer with anti-egfr agents


The present invention relates to methods for treating gastric neoplasias, in particular treating patients who have been previously determined to have an egfr biomarker. Gastric carcinoma (gc) is one of the most common and deadest cancers with −1 million diagnoses and −0.7 million deaths each year worldwide, with high incidence in eastern asia..
Crown Bioscience, Inc. (taicang)


01/28/16
20160024095 

Hedgehog pathway signaling inhibitors and therapeutic applications thereof


The hedgehog (hh) signaling pathway is a pathway which regulates patterning, growth and cell migration during embryonic development, but in adulthood is limited to tissue maintenance and repair. Mutational inactivation of the inhibitory pathway components leads to constitutive ligand-independent activation of the hh signaling pathway, results in cancers such as basal cell carcinoma and medulloblastoma.
Suzhou Yunxuan Yiyao Keji Youxian Gongsi


01/28/16
20160022808 

Method for cancer immunotherapy and pharmaceutical compositions based on oncolytic non-pathogenic sendai virus


The invention relates to the field of immunology and medicine, more specifically, oncology, and can be useful for the treatment of patients with carcinomas and sarcomas. A pharmaceutical composition is provided which contains biologically active oncolytic sendai virus strain moscow pta-13024, and a method of treating patients with said malignancies is developed including administration of the said composition to a patient's body.

01/28/16
20160022791 

Cytotoxic t lymphocyte inducing immunogens for prevention treatment and diagnosis of cancer


The present invention relates to compositions and methods for the prevention, treatment, and diagnosis of cancer, especially carcinomas, such as lung carcinoma. The invention discloses peptides, polypeptides, and polynucleotides that can be used to stimulate a ctl response against lung and other cancers..
Immunotope, Inc.


01/28/16
20160022789 

Individualized high purity colon carcinoma stem cells, methods and use of the same


The disclosure provides cancer stem cells, for use in stimulating immune response against a cancer, such as colon carcinoma (cc). Methods for preparing and purifying the cancer stem cells are provided..
Neostem Oncology, Llc


01/28/16
20160022606 

Novel therapy for prostate carcinoma


Disclosed herein are methods of inhibiting or delaying the growth of androgen-dependent prostate cancer, and/or inhibiting or delaying the onset of castration-resistant prostate cancer (crpc) by administering naphthoquinone analogs, such as plumbagin, and specified hormone therapy agents, including selective inhibitors of 17,20-lyase activity of cyp 17.. .
Pellficure Pharmaceuticals Inc.


01/21/16
20160021390 

Method and system for modifying compressive sensing block sizes for video monitoring using distance information


A method and a system for using compression sensing to provide low data rate transmission and low computational complexity to determine anomalies in video data obtained by a video camera or other motion detection device. The video data is divided into varying sized video blocks based on an anticipated size of objects of interest within the video, and based on a distance between a video camera and the objects of interest.
Alcatel-lucent Usa, Inc.


01/21/16
20160021135 

System and method thereof for creating programmable security decision engines in a cyber-security system


A system and method for adaptively securing a protected entity against cyber-threats. The method comprises: determining, based on at least one input feature, at least one normalization function, wherein the at least one input feature defines an attribute of a data flow to be evaluated by the sde; receiving at least one engine rule describing an anomaly to be evaluated; and creating an inference system including at least one inference unit, wherein each inference unit is determined based on one of the received at least one engine rule, wherein the inference system computes a score of anomaly (soa) respective of the at least one input feature..
Empow Cyber Security Ltd.


01/21/16
20160021128 

Method for detecting an attack in a computer network


A method for detecting an attack in a computer network having a plurality of computers includes: receiving a plurality of warning messages from the computers, the warning messages being based on different types of anomalies in the computer network; comparing a number of warning messages from the plurality of received warning messages with a predetermined event threshold, the number of warning messages being based on a single type of anomaly in the computer network; and outputting an alarm signal if the number of warning messages based on the same type of anomaly in the computer network falls below the event threshold.. .
Deutsche Telekom Ag


01/21/16
20160021122 

Explaining causes of network anomalies


In an embodiment, the method comprises receiving network performance data for a computer network; receiving, from an intrusion detection system, network anomaly data indicating a plurality of anomalies that have occurred in the computer network; based, at least in part, on the network performance data and the network anomaly data, generating feature data; for each anomaly of the plurality of anomalies, using the feature data to determine a minimal set of features that distinguishes the anomaly from non-anomalies in the plurality of anomalies, and creating a mapping of the anomaly to the minimal set of features; based at least in part on the mapping, generating explanation rules for the plurality of anomalies; for a particular anomaly, identifying a particular rule of the explanation rules that is associated with the particular anomaly, and generating explanation data for the particular anomaly based upon the particular rule.. .
Cisco Technology, Inc.


01/21/16
20160019337 

Subtyping lung cancers


This disclosure concerns the identification of biomarkers that are characteristic of squamous or non squamous (e.g., adenocarcinoma, large cell carcinoma, carcinoid tumor, sarcomatoid carcinoma) subtypes of non small cell lung cancer (nsclc), clinically useful nsclc classifiers, kits and arrays for distinguishing squamous and nonsquamous nsclc subtypes, bioinformatic methods for determining clinically useful classifiers, and methods of use of each of the foregoing.. .
Htg Molecular Diagnostics, Inc.


01/21/16
20160018550 

Direct fluid indicators in multiple segment prospects


Methods, systems, and computer-readable media for determining a chance of success for a prospect including two or more segments. The method may include receiving seismic data indicative of a plurality of anomalies in a prospect.
Schlumberger Technology Corporation


01/21/16
20160018399 

Methods and materials for identifying and treating mammals having lung adenocarcinoma characterized by neuroendocrine differentiation


This document provides methods and materials involved in identifying mammals having lung adenocarcinoma characterized by neuroendocrine differentiation as well as methods and materials involved in treating mammals having lung adenocarcinoma characterized by neuroendocrine differentiation. For example, methods and materials for using ascl1 and ret expression levels to identify lung cancer patients having lung adenocarcinoma characterized by neuroendocrine differentiation are provided..
Mayo Foundation For Medical Education And Research


01/21/16
20160017430 

Method for the identification of the origin of a cancer of unknown primary origin by methylation analysis


The invention relates to methods and reagents for the identification of the origin of a carcinoma of unknown primary origin (cup) based on the determination of the methylation profile in the genome of the cup. The invention relates as well to methods for selecting a suitable therapy for a patient suffering a cup as well as to methods for personalized medicine of patient suffering a cup based on the use of a treatment which is adequate for the primary tumor from which the cup is derived.
FundaciÓ InstituciÓ Catalana De Recerca I Estudis AvanÇats


01/21/16
20160017412 

Non-invasive prenatal diagnosis of fetal genetic condition using cellular dna and cell free dna


Disclosed are methods for determining at least one sequence of interest of a fetus of a pregnant mother. In various embodiments, the method can determine one or more sequences of interest in a test sample that comprises a mixture of maternal cellular dna and mother-and-fetus cfdna.
Illumina, Inc.


01/21/16
20160017293 

Individualized high purity hepatocellular carcinoma stem cells, methods and use of the same


The disclosure provides cancer stem cells, for use in stimulating immune response against a cancer, such as hepatocellular carcinoma (hcc). Methods for preparing and purifying the cancer stem cells are provided..
Neostem Oncology, Llc


01/21/16
20160017292 

Selective targeting of cancer stem cells


Aspects of the invention relate to methods and related compositions for preferentially targeting cancer stem cells. In some embodiments, the methods utilize pkc-α/fra1 pathway inhibitors to target carcinoma cells.
Whitehead Institute For Biomedical Research


01/21/16
20160017128 

Chemically multi-functional nanomaterials for composite structures and production thereof


A chemically multi-functional nanomaterial for use as binding agent in composite structures having at least two components chemically different from each other, wherein said chemically multi-functional nanomaterial is provided with a first functional group and at least a second functional group different from said first functional group, is proposed. Also two alternative methods for production of said chemically multi-functional nanomaterial is proposed.
Sabanci Üniversitesi


01/21/16
20160016796 

Sorting two-dimensional nanomaterials by thickness


The present teachings provide, in part, methods of separating two-dimensional nanomaterials by atomic layer thickness. In certain embodiments, the present teachings provide methods of generating boron nitride nanomaterials having a controlled number of atomic layer(s)..

01/21/16
20160015971 

Nanosecond pulsed electric fields cause melanomas to self-destruct


Methods for a new, drug-free therapy for treating solid skin tumors through the application of nanosecond pulsed electric fields (“nspefs”) are provided. In one embodiment of the invention, the cells are melanoma cells, and the applied nspefs penetrate into the interior of tumor cells and cause tumor cell nuclei to rapidly shrink and tumor blood flow to stop.
Old Dominion University Research Foundation


01/21/16
20160015691 

Use of mtor inhibitors for prevention of neuroendocrine tumor development and growth


Disclosed are methods and compositions for the prevention or inhibition of the growth of endocrine-related adenomas, neoplasia, or dysplasia in a patient who has been identified as being at risk for developing an endocrine tumor or endocrine cancer. The disclosed methods and compositions include rapamycin, a rapamycin analog, or another such inhibitor of the target of rapamycin (tor)..
The Board Of Regents Of The University Of Texas System


01/21/16
20160015688 

Compounds for treatment of cancer


The present invention relates to pharmaceutical compositions for treating cancer comprising braf inhibitors, (e.g. Vemurafenib) and/or mek inhibitor, (e.g.
University Of Tennessee Research Foundation


01/21/16
20160015652 

Hollow nanoparticles with hybrid double layers


The present invention discloses the morphology of hollow, double-shelled submicrometer particles generated through a rapid aerosol-based process. The inner shell is an essentially hydrophobic carbon layer of nanoscale dimension (5-20 nm), and the outer shell is a hydrophilic silica layer of approximately 5-40 nm, with the shell thickness being a function of the particle size.
The Administrators Of The Tulane Educational Fund


01/21/16
20160015646 

Oral delivery system for sorafenib tosylate


The present invention relates to a gastroretentive tablet for treating unresectable hepatocellular carcinoma, comprising an enteric polymer, a nanoparticle and an excipient, wherein the nanoparticle comprises an oral multikinase inhibitor, wherein the oral multikinase inhibitor is coated with an amino methacrylate copolymer, wherein the oral multikinase inhibitor is sorafenib, and wherein the enteric polymer is methacrylic acid copolymer. The excipient is selected from a group consisting of a retarding agent, a binder, a filler, a diluent, a disintegrant, a lubricant, a colorant, a solubilizing agent, or a mixture thereof..

01/14/16
20160014148 

Web anomaly detection apparatus and method


Provided is an apparatus and a method for detecting a web anomaly. Traditional web anomaly detection is performed by matching a signature of an attack to previously known signatures.
Soteria Systems Llc


01/14/16
20160012544 

Insurance claim validation and anomaly detection based on modus operandi analysis


In one aspect, a method of computer-implemented insurance claim validation based on arm (pattern analysis, recognition and matching) approach and anomaly detection based on modus operandi analysis including the step of obtaining a set of open claims data. One of more modus-operandi variables of the open claims set are determined.

01/14/16
20160012356 

Automated tracker and analyzer


A utility that can be embedded within a system or application, or run as a stand-alone utility, provides a method for identifying causal relationships for one or more events. For instance, if an anomaly is occurring for a subset of events in a series of events, certain information about potential causes can be collected in conjunction with the series of events and, the information can be analyzed to determine if there is a cause and affect relationship leading to the occurrence of the anomalies..

01/14/16
20160011862 

Methods and improving compatibility between network devices


In some embodiments, an apparatus includes a network device configured to receive an anomaly database of a first image that stores a set of differences between the first image and a base image. The network device is configured to compare the anomaly database of the first image with an anomaly database of a second image storing a set of differences between the second image and the base image to determine if the first and second images include at least one incompatible critical feature or incompatible non-critical feature.
Juniper Networks, Inc.


01/14/16
20160011022 

Systems and methods for detecting a magnetic anomaly


Systems and methods are disclosed for detecting when a magnetic anomaly may impact the quality of data being output by a magnetometer. A plurality of detection algorithms may be performed in parallel on the sensor data.
Invensense, Incorporated


01/14/16
20160010089 

Organic compositions to treat epasi-related diseases


The present disclosure relates to methods of treating epas1-related diseases such as cancer, metastases, astrocytoma, bladder cancer, breast cancer, chondrosarcoma, colorectal carcinoma, gastric carcinoma, glioblastoma, head and neck squamous cell carcinoma, hepatocellular carcinoma, lung adenocarcinoma, neuroblastoma, non-small cell lung cancer, melanoma, multiple myeloma, ovarian cancer, rectal cancer, renal cancer, clear cell renal cell carcinoma (and metastases of this and other cancers), gingivitis, psoriasis, kaposi's sarcoma-associated herpesvirus, preemclampsia, inflammation, chronic inflammation, neovascular diseases, and rheumatoid arthritis, using a therapeutically effective amount of a rnai agent to epas1.. .
Arrowhead Research Corporation


01/14/16
20160010088 

Method for inhibiting tumor growth through rna-interference using liposomally associated cdc20 sirna


Liposomal compositions comprising of liposomes of guanidinylated cationic amphiphiles as the main lipid and cholesterol/1,2-dioleoyl-sn-glycero-3-phosphocholine (dopc)/aminopropyl polyethyleneglycol carbamyl-distearoylphosphatidyl-ethanolamine (dspe-peg-nh2) as co-lipids are described. These liposomal compositions containing encapsulated or electrostatically complexed therapeutic small interfering rnas (sirnas) against cdc20, a key cell cycle regulator, inhibit solid tumor growth and melanoma tumor growth on lung in c57bl/6j mice..
Council Of Scientific & Industrial Research


01/14/16
20160010068 

Fusion polynucleotides and fusion polypeptides associated with cancer and particularly melanoma and their uses as therapeutic and diagnostic targets


Novel fusion molecules and uses are disclosed.. .

01/14/16
20160009934 

Highly conductive material formed by hybridization of metal nanomaterial and carbon nanomaterial having higher-order structure due to multiple hydrogen bonding, and manufacturing method therefor


The present invention relates to a highly conductive material formed by hybridization of a metal nanomaterial and a carbon nanomaterial having a higher-order structure due to multiple hydrogen bonding, and to a manufacturing method therefor. The technical essence of the present invention is a highly conductive material formed by hybridization of a metal nanomaterial and a carbon nanomaterial having a higher-order structure due to multiple hydrogen bonding the invention involving: forming a carbon nanomaterial having a higher-order structure due to multiple hydrogen bonding between conductive carbon nanomaterials by introducing a functional group capable of multiple hydrogen bonding to the carbon nanomaterials; forming a composite material by mixing the carbon nanomaterial having a higher-order structure and a metal nanomaterial..
Korea Electrotechnology Research Institute


01/14/16
20160009815 

Methods for manipulating phagocytosis mediated by cd47


Methods are provided to manipulate phagocytosis of cancer cells, including e.g. Leukemias, solid tumors including carcinomas, etc..
The Board Of Trustees Of The Leland Stanford Junior University


01/14/16
20160009814 

Methods for manipulating phagocytosis mediated by cd47


Methods are provided to manipulate phagocytosis of cancer cells, including e.g. Leukemias, solid tumors including carcinomas, etc..
The Board Of Trustees Of The Leland Stanford Junior University


01/14/16
20160009804 

Therapeutic and diagnostic methods relating to cancer stem cells


The present invention relates in part to the discovery of genes that are deregulated in cancer stem cells (e.g., melanoma stem cells). In some aspects, methods for treating individuals having melanoma are provided; the methods involve modulating (e.g., inducing, inhibiting, etc.) the activity of the cancer stem cell associated genes.
The Brigham And Women's Hospital, Inc.


01/14/16
20160008497 

Method for treating lung carcinoma


Accordingly, the present invention provides a method of treating lung neoplasia in a subject in need of treatment, by subjecting the patient to sirt.. .
Sirtex Medical Limited


01/14/16
20160008487 

Duocarmycin adcs for use in treatment of endometrial cancer


The present invention relates to duocarmycin-containing antibody-drug conjugates (adcs) for use in the treatment of human solid tumours expressing her2, wherein the human solid tumour expressing her2 is endometrial cancer, in particular uterine serous carcinoma (usc). In particular, the present invention relates to duocarmycin-containing adcs for use in the treatment of endometrial cancer, notably usc, with her2 ihc 2− or 1+ and her2 fish negative tumour tissue status..
Yale University


01/14/16
20160008446 

Autologous tumor lysate-loaded dendritic cell vaccine for treatment of liver cancer


The present disclosure provides compositions comprising mature dendritic cells loaded with autologous tumor cell lysates for the treatment of liver cancers, such as hepatocellular carcinoma. Hepatocellular carcinoma (hcc) is the fifth leading cancer and third leading cause of cancer-related mortality worldwide.
Icahn School Of Medicine At Mount Sinai


01/14/16
20160008332 

Combinatorial compositions and methods for treatment of melanoma


Embodiments described here are combinatorial compositions and methods using these compositions for treating melanomas having activated mutations. The compositions comprises combinations of inhibitors of a mapk pathway, erk inhibitors, egfr inhibitors, oxidative phosphorylation (oxphos) inhibitors, inhibitors of b-raf, mitochondrial inhibitors, c-kit inhibitors, mek inhibitors and tigecycline or a derivative thereof..
The General Hospital Corporation


01/14/16
20160008316 

Use of dianhydrogalactitol and analogs or derivatives thereof in combination with platinum-containing antineoplastic agents to treat non-small-cell carcinoma of the lung and brain metastases


The use of dianhydrogalactitol provides a novel therapeutic modality for the treatment of non-small-cell lung carcinoma (nsclc) and ovarian cancer, as well as other types of malignancy, including brain metastases of nsclc. Dianhydrogalactitol acts as an alkylating agent on dna that creates n7 methylation.
Del Mar Pharmaceuticals


01/14/16
20160008302 

Compounds and methods for treating aberrant adrenocortical cell disorders


Methods and compositions are provided for treatment of disorders associated with aberrant adrenal cortex cell behavior, including (but not limited to) treatment of adrenocortical carcinoma (acc), cushing's syndrome and/or pituitary acth excess (cushing's disease). Such methods involve administration of an effective amount n-(2,6-bis(1-methylethyl)phenyl)-n′-((1-(4-(dimethylamino)phenyl)cyclopentyl)-methyl)urea hydrochloride to the patient..
Atterocor, Inc.


01/14/16
20160007907 

Diagnostic methods and device


The present invention relates to a method of diagnosing, or providing a prognosis to, or for providing the likelihood of developing, malignant melanoma in a subject, the method comprising the steps of: (a) measuring two or more markers in blood perfusion dynamics at and/or around a skin lesion site; and (b) determining if the two or more markers is different to a normal value. The invention also relates to a device for diagnosing/providing a prognosis to/for malignant melanoma in a subject..
Lancaster University Business Enterprises Limited


01/07/16
20160007172 

Method, terminal, and system for implementing call forwarding


A method, a terminal, and a system for implementing call diversion. The method comprises: when a call access anomaly of a request terminal occurs, setting and sending call forwarding request information to a target terminal; the target terminal reading a call forwarding identification in the call forwarding request information, determining whether the call forwarding identification is correct, and if yes, reading an address of the target terminal in the call forwarding request information; the target terminal determining whether the address of the target terminal is correct, and if yes, reading a forwarding address identification in the call forwarding request information, setting a forwarding terminal address according to the forwarding address identification, and setting and sending call forwarding success response information to the request terminal; and the request terminal receiving the call forwarding success response information and setting up call forwarding..
Hytera Communications Corp., Ltd.


01/07/16
20160005211 

System and three-dimensional model generation


A method includes generating, at an electronic device, a three-dimensional model of an object based on a sequence of images captured by an image capture device associated with the electronic device. The method further includes displaying the three-dimensional model via a display device associated with the electronic device.
Qualcomm Incorporated






Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Noma for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Noma with additional patents listed. Browse our RSS directory or Search for other possible listings.


1.1813

4826

0 - 1 - 101